TNBC versus other tumor subtype was significantly more frequent among AA patients with pathogenic variants in BRCA2 or PALB2 than among AA cases with no such variants (OR = 2.95 [1.18, 7.37]). This evidence concerns the gene PALB2 and neoplasm.